Suppr超能文献

射血分数保留的心力衰竭患者静息心室-血管功能与运动能力:一项RELAX试验的辅助研究

Resting ventricular-vascular function and exercise capacity in heart failure with preserved ejection fraction: a RELAX trial ancillary study.

作者信息

Mohammed Selma F, Borlaug Barry A, McNulty Steven, Lewis Gregory D, Lin Grace, Zakeri Rosita, Semigran Marc J, LeWinter Martin, Hernandez Adrian F, Braunwald Eugene, Redfield Margaret M

机构信息

From the Division of Cardiovascular Diseases (S.F.M., B.A.B., G.L., R.Z., M.M.R.) and Mayo Graduate School (S.F.M., R.Z.), Mayo Clinic, Rochester, MN; Duke Clinical Research Institute, Durham, NC (S.M., A.F.H.); Massachusetts General Hospital, Boston, MA (G.D.L., M.J.S.); University of Vermont, Burlington, VT (M.L.); and Harvard Medical School, Boston, MA (E.B.).

出版信息

Circ Heart Fail. 2014 Jul;7(4):580-9. doi: 10.1161/CIRCHEARTFAILURE.114.001192. Epub 2014 May 15.

Abstract

BACKGROUND

Exercise intolerance is a hallmark of heart failure, but factors associated with impaired exercise capacity in heart failure with preserved ejection fraction are unclear. We hypothesized that in heart failure with preserved ejection fraction, the severity of resting ventricular and vascular dysfunction are associated with impairment in exercise tolerance as assessed by peak oxygen consumption.

METHODS AND RESULTS

Subjects with heart failure with preserved ejection fraction enrolled in the PhosphodiesteRasE-5 Inhibition to Improve CLinical Status And EXercise Capacity in Diastolic Heart Failure (RELAX) clinical trial (n=216) underwent baseline Doppler echocardiography, cardiopulmonary exercise testing, and cardiac MRI. RELAX participants were elderly (median age 69 years) and 48% were women. Ejection fraction (60%) and stroke volume (77 mL) were normal, while diastolic dysfunction (medial E/e', 16; deceleration time, 185 ms; left atrial volume, 44 mL/m(2)) and increased arterial load (arterial elastance, 1.51 mm Hg/mL) were evident. Peak oxygen consumption was reduced (11.7 mLkg(-1)min(-1), 1141 mL/min) and age, sex, body mass index, hemoglobin, and chronotropic response collectively explained 64% of the variance in raw peak oxygen consumption (mL/min). After adjustment for these variables, left ventricular structure (diastolic dimension [1.5%, P=0.008] and left ventricular mass [1.6%, P=0.008]), resting stroke volume (2.0%, P=0.002), left ventricular diastolic dysfunction (deceleration time [0.9%, P=0.03] and E/e' [1.4%, P=0.009]), and arterial function (arterial elastance [2.1%, P=0.002] and systemic arterial compliance [1.5%, P=0.007]), each explained only a small additional portion of the variance in peak oxygen consumption.

CONCLUSIONS

In heart failure with preserved ejection fraction, potentially modifiable factors (obesity, anemia, and chronotropic incompetence) are strongly associated with exercise capacity, whereas resting measures of ventricular and vascular structure and function are not.

CLINICAL TRIAL REGISTRATION URL

http://www.clinicaltrials.gov. Unique identifier: NCT00763867.

摘要

背景

运动耐量下降是心力衰竭的一个标志,但射血分数保留的心力衰竭患者运动能力受损的相关因素尚不清楚。我们假设,在射血分数保留的心力衰竭患者中,静息时心室和血管功能障碍的严重程度与通过峰值耗氧量评估的运动耐量受损有关。

方法和结果

参与舒张性心力衰竭磷酸二酯酶-5抑制改善临床状态和运动能力(RELAX)临床试验(n = 216)的射血分数保留的心力衰竭患者接受了基线多普勒超声心动图、心肺运动试验和心脏磁共振成像检查。RELAX试验参与者为老年人(中位年龄69岁),48%为女性。射血分数(60%)和每搏输出量(77 mL)正常,而舒张功能障碍(平均E/e',16;减速时间,185 ms;左心房容积,44 mL/m²)和动脉负荷增加(动脉弹性,1.51 mmHg/mL)明显。峰值耗氧量降低(11.7 mL·kg⁻¹·min⁻¹,1141 mL/min),年龄、性别、体重指数、血红蛋白和变时反应共同解释了原始峰值耗氧量(mL/min)变异的64%。在对这些变量进行校正后,左心室结构(舒张末期内径[1.5%,P = 0.008]和左心室质量[1.6%,P = 0.008])、静息每搏输出量(2.0%,P = 0.002)、左心室舒张功能障碍(减速时间[0.9%,P = 0.03]和E/e'[1.4%,P = 0.009])以及动脉功能(动脉弹性[2.1%,P = 0.002]和全身动脉顺应性[1.5%,P = 0.007]),各自仅解释了峰值耗氧量变异中一小部分额外变异。

结论

在射血分数保留的心力衰竭患者中,潜在可改变的因素(肥胖、贫血和变时功能不全)与运动能力密切相关,而心室和血管结构及功能的静息指标则不然。

临床试验注册网址

http://www.clinicaltrials.gov。唯一标识符:NCT00763867。

相似文献

1
Resting ventricular-vascular function and exercise capacity in heart failure with preserved ejection fraction: a RELAX trial ancillary study.
Circ Heart Fail. 2014 Jul;7(4):580-9. doi: 10.1161/CIRCHEARTFAILURE.114.001192. Epub 2014 May 15.
3
Contributions of Nondiastolic Factors to Exercise Intolerance in Heart Failure With Preserved Ejection Fraction.
J Am Coll Cardiol. 2016 Feb 16;67(6):659-670. doi: 10.1016/j.jacc.2015.10.096.
4
Impact of atrial fibrillation on exercise capacity in heart failure with preserved ejection fraction: a RELAX trial ancillary study.
Circ Heart Fail. 2014 Jan;7(1):123-30. doi: 10.1161/CIRCHEARTFAILURE.113.000568. Epub 2013 Oct 25.
5
Suppression of Tumorigenicity 2 in Heart Failure With Preserved Ejection Fraction.
J Am Heart Assoc. 2017 Feb 18;6(2):e004382. doi: 10.1161/JAHA.116.004382.
7
Left ventricular diastolic dysfunction and exercise intolerance in obese heart failure with preserved ejection fraction.
Am J Physiol Heart Circ Physiol. 2021 Apr 1;320(4):H1535-H1542. doi: 10.1152/ajpheart.00610.2020. Epub 2021 Feb 12.

引用本文的文献

1
2
Heart Failure With Preserved Ejection Fraction: An Evolving Understanding.
Cureus. 2023 Sep 28;15(9):e46152. doi: 10.7759/cureus.46152. eCollection 2023 Sep.
3
Development and validation of equation for cardiorespiratory fitness in patients with heart failure with preserved ejection fraction.
Korean J Intern Med. 2023 Jul;38(4):514-525. doi: 10.3904/kjim.2022.375. Epub 2023 Jun 20.
4
Vascular dysfunction in HFpEF: Potential role in the development, maintenance, and progression of the disease.
Front Cardiovasc Med. 2022 Dec 21;9:1070935. doi: 10.3389/fcvm.2022.1070935. eCollection 2022.
5
Non-invasive assessment of HFpEF in mouse models: current gaps and future directions.
BMC Med. 2022 Oct 14;20(1):349. doi: 10.1186/s12916-022-02546-3.
6
Diabetes Is the Strongest Predictor of Limited Exercise Capacity in Chronic Heart Failure and Preserved Ejection Fraction (HFpEF).
Front Cardiovasc Med. 2022 May 26;9:883615. doi: 10.3389/fcvm.2022.883615. eCollection 2022.
7
Exercise Blood Pressure in Heart Failure With Preserved and Reduced Ejection Fraction.
JACC Heart Fail. 2022 Apr;10(4):278-286. doi: 10.1016/j.jchf.2022.01.012. Epub 2022 Mar 9.
8
Right Heart Phenotype in Heart Failure With Preserved Ejection Fraction.
Circ Heart Fail. 2021 Apr;14(4):e007840. doi: 10.1161/CIRCHEARTFAILURE.120.007840. Epub 2021 Apr 19.
10
Cellular and molecular pathobiology of heart failure with preserved ejection fraction.
Nat Rev Cardiol. 2021 Jun;18(6):400-423. doi: 10.1038/s41569-020-00480-6. Epub 2021 Jan 11.

本文引用的文献

7
Cardiac output response to exercise in relation to metabolic demand in heart failure with preserved ejection fraction.
Eur J Heart Fail. 2013 Jul;15(7):776-85. doi: 10.1093/eurjhf/hft026. Epub 2013 Feb 20.
9
Comorbidity and ventricular and vascular structure and function in heart failure with preserved ejection fraction: a community-based study.
Circ Heart Fail. 2012 Nov;5(6):710-9. doi: 10.1161/CIRCHEARTFAILURE.112.968594. Epub 2012 Oct 17.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验